Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Coronado Biosciences, Falk, OvaMed In TSO Pact | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Coronado Biosciences, Falk, OvaMed In TSO Pact

Will develop Crohn's disease drug in U.S. and Europe

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Coronado Biosciences, Inc. has signed a collaboration agreement with Dr. Falk Pharma GmbH and OvaMed GmbH for the development of TSO (Trichuris suis ova or CNDO-201) for Crohn’s disease.

Falk has granted Coronado exclusive rights and licenses for certain preclinical data and clinical data from Falk’s clinical trials of TSO in Crohn’s disease, including an ongoing Phase II trial, for use in North America, South America and Japan. Coronado granted Falk exclusive rights and licenses to data from Coronado’s clinical trials of TSO in Crohn’s disease for use in Europe. Falk will receive a total of $6.6 million after receipt of certain preclinical and clinical data and a royalty of 1% of TSO sales.

Coronado licensed TSO, an orally administered, natural immunomodulator that regulates T-Cells and inflammatory cytokines, from OvaMed, the manufacturer of the product, in North America, South America and Japan. Falk licensed TSO from OvaMed for gastroenterology indications in Europe. Coronado and Falk will each be responsible for clinical testing for regulatory approval of TSO for Crohn’s disease in the U.S. and Europe, and will share certain preclinical development costs.

 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics